Tsai and Ed Boyden, a colleague at MIT and co-author, have started a company called Cognito Therapeutics to pursue tests in humans.
For instance, he said that a computer programmer from Washington and a urologist from Phoenix had decided to pursue testing as a second career.
Our analysis showed that all of the demographic and psychological control variables in our model were statistically significantly related to being "very likely" to pursue testing.
Among those with an abnormal result: 3/5 contacted Clinical Genetics and 2/3 scheduled an appointment, were counseled and tested the remaining 2/5 received counseling concurrent with a medical oncology appointment, and 1 pursued further testing, while the other, a 23 year-old with CRC and a family history of LS, has yet to pursue testing.
For example, holding all else constant, the odds of being "very likely" to pursue testing were 76% higher for those worried about developing AD than for those not worried.
Polysomnography was done based upon pulmonologist's decision to pursue testing for OSA based upon findings of sleep history, physical exam consistent with a possibility of sleep disordered breathing and results of overnight oximetry.
Country-level differences were also particularly striking - Spain and Poland had the highest shares of respondents reporting that they were "very likely" to pursue testing (39.6% and 30.5%) and Germany the lowest (23.6%).
Overall, we found that more than two-thirds of respondents across all countries would be "very likely" (30%) or "somewhat likely" (37%) to obtain an early medical test if it were available in the future; 21.1% would be "not too likely," and 11.9% would be "not at all likely" to pursue testing.
We expect those with high levels of perceived risk - those who are worried about getting AD as well as those with more experience with the disease, including caregivers and blood relatives of AD patients - will be among those most likely to pursue testing once it becomes available.
After result disclosure, 98.7% of patients were glad they pursued testing.
For confirmation, we pursued testing with EV-D68 specific EV-D68 specificPCRformed by the Special Projects Laboratory of the whichngton University Department of Pediatrics.
